Needham & Company LLC initiated coverage on shares of Livongo Health (NASDAQ:LVGO) in a report issued on Monday morning, BenzingaRatingsTable reports. The brokerage issued a buy rating and a $42.00 target price on the stock.

LVGO has been the subject of a number of other reports. Leerink Swann started coverage on shares of Livongo Health in a report on Monday. They issued an outperform rating and a $50.00 price target for the company. Chardan Capital started coverage on shares of Livongo Health in a report on Friday, August 16th. They issued a neutral rating and a $40.00 price target for the company. Finally, Piper Jaffray Companies started coverage on shares of Livongo Health in a report on Monday. They issued an overweight rating and a $40.00 price target for the company. Two investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. Livongo Health presently has a consensus rating of Buy and an average target price of $44.20.

Shares of Livongo Health stock opened at $35.42 on Monday. Livongo Health has a fifty-two week low of $31.60 and a fifty-two week high of $45.68.

In other Livongo Health news, Director Hemant Taneja acquired 2,678,571 shares of Livongo Health stock in a transaction dated Monday, July 29th. The stock was bought at an average cost of $28.00 per share, with a total value of $74,999,988.00. The purchase was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, major shareholder Ab (Publ) Kinnevik acquired 3,141,795 shares of Livongo Health stock in a transaction dated Monday, July 29th. The shares were acquired at an average cost of $28.00 per share, with a total value of $87,970,260.00. The disclosure for this purchase can be found here.

About Livongo Health

Livongo Health, Inc provides an integrated suite of solutions for the healthcare industry in North America. It solutions promote health behavior change based on real-time data capture supported by intuitive devices and insights driven by data science. The company offers a platform that provides cellular-connected devices, supplies, informed coaching, data science-enabled insights, and facilitates access to medications.

Recommended Story: Using the New Google Finance Tool

Analyst Recommendations for Livongo Health (NASDAQ:LVGO)

Receive News & Ratings for Livongo Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Livongo Health and related companies with MarketBeat.com's FREE daily email newsletter.